Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at info@axialvc.com
Debut uses cell-free biomanufacturing for ingredients, chemicals, and more. Founded in 2019, by Joshua Britton, Brady Beauchamp, and Greg Weiss, Debut focuses on using biotech to build brands. With a fully-integrated platform & various partnerships in health/food.
The platform relies on enzyme immobilization. Debut actually pivoted from a cartridge/consumable model to fully-integrated. Similar to other cell-free startups Debut iterates across enzyme designs to find an efficient catalyst & enable reactions not possible with traditional ones.
Debut has partnerships with GeneChem for HMOs in infant formula, DIC for natural color ingredients in food & cosmetics, and Royal DSM for ingredients. Cell-free allows for continuous manufacturing & a plug-and-play approach for their enzymes across a wide-range of applications.
Fermentation with cells often encounters issues with cycle times, lower titers, & product toxicities. Cell-free can overcome the limits of the cell with optimized enzymes and the right conditions. Learn more about Debut here: https://www.debutbiotech.com/